Hepatocellular carcinoma-specific immunotherapy with synthesized α1,3- galactosyl epitope-pulsed dendritic cells and cytokine-induced killer cells

AIM: To evaluate the safety and clinical efficacy of a new immunotherapy using both α-Gal epitope-pulsed dendritic cells (DCs) and cytokine-induced killer cells. METHODS: Freshly collected hepatocellular carcinoma (HCC) tumor tissues were incubated with a mixture of neuraminidase and recombinant α1,...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Qiu, Ying, Xu, Ming-Bao, Yun, Mark M, Wang, Yi-Zhong, Zhang, Rui-Ming, Meng, Xing-Kai, Ou-Yang, Xiao-Hui, Yun, Sheng
Format: Artigo
Langue:Inglês
Publié: Baishideng Publishing Group Co., Limited 2011
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3247689/
https://ncbi.nlm.nih.gov/pubmed/22219594
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v17.i48.5260
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires